These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Morris JC Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163 [TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551 [TBL] [Abstract][Full Text] [Related]
10. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663 [TBL] [Abstract][Full Text] [Related]
11. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618 [TBL] [Abstract][Full Text] [Related]
13. The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment. Giunta M; Rigamonti AE; Scarpini E; Galimberti D; Bonomo SM; Venturelli E; Müller EE; Cella SG Neurobiol Aging; 2007 Apr; 28(4):515-8. PubMed ID: 16563568 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169 [TBL] [Abstract][Full Text] [Related]
15. Oxidative inactivation of the proteasome in Alzheimer's disease. Cecarini V; Ding Q; Keller JN Free Radic Res; 2007 Jun; 41(6):673-80. PubMed ID: 17516240 [TBL] [Abstract][Full Text] [Related]
16. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167 [TBL] [Abstract][Full Text] [Related]
17. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Paquet C; Boissonnot M; Roger F; Dighiero P; Gil R; Hugon J Neurosci Lett; 2007 Jun; 420(2):97-9. PubMed ID: 17543991 [TBL] [Abstract][Full Text] [Related]
18. Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment. Levinoff EJ; Saumier D; Chertkow H Brain Cogn; 2005 Mar; 57(2):127-30. PubMed ID: 15708202 [TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks. Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417 [TBL] [Abstract][Full Text] [Related]
20. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. Peng S; Wuu J; Mufson EJ; Fahnestock M J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]